Financial Gravity Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Financial Gravity Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-103	Closed	-$965	–	1845
2023 Q2	$965	Sell	103 -6	-6%	-$633	﹤0.01%	823
2023 Q1	$333	Sell	109 -5	-4%	-$553	0.01%	519
2022 Q4	$17.2K	Sell	114 -444	-80%	-$36.9K	0.09%	126
2022 Q3	$201	Sell	558 -162	-23%	-$11.3K	0.01%	550
2022 Q2	$259	Sell	720 -120	-14%	-$11.4K	0.01%	496
2022 Q1	$339	Sell	840 -132	-14%	-$12.9K	0.01%	485
2021 Q4	$353	Buy	972 +969	+32,300%	+$106K	0.01%	542
2021 Q3	$110K	Buy	+3	New	+$311	0.05%	333
2019 Q4	–	Sell	-16	Closed	–	–	1847
2019 Q3	$0	Buy	16 +2	+14%	+$52	﹤0.01%	1714
2019 Q2	$0	Buy	14 +7	+100%	+$178	﹤0.01%	1849
2019 Q1	$0	Buy	+7	New	+$166	﹤0.01%	1644
2018 Q3	$2K	Buy	123 +20	+19%	+$380	﹤0.01%	1049
2018 Q2	$2K	Buy	103 +14	+16%	+$213	﹤0.01%	1068
2018 Q1	$1K	Buy	+89	New	+$1.31K	﹤0.01%	1352

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Financial Gravity Asset Management's HZNP Position: Q3 2023 in Review

Financial Gravity Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 103 shares — an estimated $965 sold.

Financial Gravity Asset Management first reported a position in HZNP in Q1 2018 and held it in 14 quarters. The position peaked at $110K in Q3 2021. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

Financial Gravity Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Financial Gravity Asset Management sold 103 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $965.
Financial Gravity Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 14 quarters.
Financial Gravity Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $110K in Q3 2021.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Financial Gravity Asset Management's 13F filing for Q3 2023, filed 16 Nov 2023.